Delivery Order SPE2DB24D2012-SPE2DB25FBWSJ
- Not listed
- The Defense Logistics Agency awarded a $26,473.25 delivery order to AmerisourceBergen Drug Corp for Qualipta 60 mg tablets (30-count units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Qualipta 60 mg tablets (30-count units) under a firm fixed-price contract valued at $10,307.65. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of August 19, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters as a leading...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Qualipta 60 mg tablets in a quantity of 30 units. This is a firm fixed-price delivery order with a ceiling value of $7,570.62 and an ultimate completion date of October 20, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Qualiptia 60 mg tablets in a quantity of 30 units, with a contract ceiling value of $3,736.62. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract is scheduled for...
- The Defense Logistics Agency awarded a delivery order valued at $3,851.85 to AmerisourceBergen Drug Corp for the supply of Qualiptia 60 mg tablets (30-count packages) on June 4, 2025, with completion targeted for June 5, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Qualipta™ 60 mg tablets (30-count) with a ceiling value of $3,947.30. This is a firm fixed-price delivery order with an ultimate completion date of June 4, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,157.61 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Qualiptia 60 mg tablets in a quantity of 30 units. This contract, which is a non-set-aside award issued under firm fixed pricing, is scheduled for completion by July 31, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a competitive award to AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at approximately $20,000 to AmerisourceBergen Drug Corp for the supply of Qualipta 60 mg tablets (30-count units). The contract, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor providing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 1, 2025, for the supply of Qualiptа 60 mg tablets (30-count units) under a firm fixed price contract with a ceiling value of $3,728.78 and an ultimate completion date of April 2, 2025. This non-competitive delivery order represents a single pharmaceutical supply transaction executed through the company's existing contract vehicle with DLA. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a $1,154.79 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Qualiptia 60 mg, with an ultimate completion date of July 17, 2025. This non-set-aside contract was competitively awarded and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award reflects routine federal pharmaceutical procurement to support military and veteran healthcare systems through the Defense...
- SPE2DB24D2012Indefinite Delivery Contract
- SPE2DB24D2012-SPE2DB25FBWSJDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,493.78 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Qualiptu 30 mg tablets (30-count packages). This is a firm fixed price, non-set-aside contract with a completion date of August 14, 2025, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's substantial IDC vehicle enables it to supply a comprehensive range of pharmaceutical products and medical supplies globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. This delivery order exemplifies the company's role in fulfilling routine pharmaceutical supply needs for the Defense Health Agency and other federal healthcare customers through the DLA's flexible contracting framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 8/13/25 |